As far back as 1969, we have been engaged in the manufacture of bulk pharmaceutical intermediates for the worldwide veterinary pharmaceutical industry as well as the manufacture and marketing of biotechnology-based products for human pharmaceutical markets. Business is conducted through our wholly-owned subsidiaries, Dextran Products in Canada and Chemdex in the United States.
Shares Issued & Outstanding - 3,399,978
An OTC Pink Foreign Issuer - POLXF
Electronically Quoted with OTC Markets
Fiscal Year End - January 31st
Currently a SEC non-reporting issuer